Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are healthy, not physically active on a regular basis, non-smoking, and not taking any medications except possibly birth control pills.
- People whose hematocrit (a measure of red blood cells in the blood) is above 35%.
- People with no whole-body or organ-related diseases, including no diabetes.
- People with no history of eating disorders.
- Women must be using a form of birth control (such as abstinence, birth control pills, Norplant, an IUD, or condoms) and, unless on birth control pills or having had a hysterectomy, must be tested between days 0 and 7 of their menstrual cycle.
- Women who take birth control pills or have had a hysterectomy may be studied at any point in their cycle.
- People whose physical activity level falls below a set threshold, as measured by a standard activity questionnaire (confirm with trial site for exact scoring details).
Who may not be able to join:
- People who do not meet the inclusion criteria listed above, including those with a history of eating disorders or any whole-body or organ disease, including diabetes.
- People with lactose intolerance.
- People with any abnormalities in blood count or blood clotting.
- People with high triglyceride levels (above 100 mg/dL in blood).
- People whose hematocrit is below 35%.
- Women of childbearing age who are not using contraception or who are not abstinent.
- People who follow a regular exercise routine.
- People with metal implants or body piercings that cannot be removed before MRI scans.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kitt Petersen, MD, Yale University
Phone: 203-785-5447
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Improvements in insulin sensitivity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.